1 0

    FDA Site Inspection Results at Anderson Inc. Customer Facility – Permethrin and Chlorpropham Detected

    FDA Site Inspection Results at Anderson Inc. Customer Facility – Permethrin and Chlorpropham Detected

    $69.00 USD
    $69.00 USD
    Sale Sold out
    Original Request: On or around August 20th, the FDA conducted a site inspection at The Anderson Inc.’s customer’s facility, during which their products on-site were tested. The results revealed the presence of Permethrin and Chlorpropham, which necessitated a product retraction. We are requesting the results of the FDA site inspection at The Anderson Inc's customer's facility in California.
    Tags: Pharma, EIR, 2025
    • Status: Pending Fast-Track Request
    • Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity

    NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. IMPORTANT: The FDA FOIA office operations are currently suspended. We are happy to make the request but do not know when we will receive a response. Learn more about Fast-Track Requests here.

    View full details